Skip to main content
Erschienen in: Rheumatology International 5/2012

01.05.2012 | Short Communication

Parotid gland non-Hodgkin lymphoma in primary Sjögren syndrome

verfasst von: Thierry Zenone

Erschienen in: Rheumatology International | Ausgabe 5/2012

Einloggen, um Zugang zu erhalten

Abstract

The risk of malignant non-Hodgkin lymphoma is increased in primary Sjögren syndrome. In the literature, most studies evaluating this risk were conducted in tertiary reference university hospital. So, selection bias in series exists, in particular selection of the most severe cases in tertiary reference university care centers. Some studies had also a selection bias because patients were hospitalized (data were obtained from hospital discharge registries) and therefore the more severe cases were considered. Between October 1999 and November 2009, 109 adult patients were admitted to our department of internal medicine (non-university hospital, secondary level of the healthcare system, hospitalized patients and outpatient) with diagnosis of primary Sjögren syndrome. Two cases of parotid gland lymphoma occurred during the period of follow-up. No other lymphoma was detected. In this study, clinically identifiable parotid gland non-Hodgkin lymphoma occurs in 1.8% of patients with primary Sjögren syndrome. Because most non-Hodgkin lymphoma initially involves the neck organs, meticulous imaging studies mainly focused on the cervical regions are recommended in the follow-up of patients with primary Sjögren syndrome. Patients whose main complaint is persistent parotid gland swelling may have a parotid biopsy in order to diagnose non-Hodgkin lymphoma.
Literatur
1.
Zurück zum Zitat Kassan SS, Moutsopoulos HM (2004) Clinical manifestations and early diagnosis of Sjögren syndrome. Arch Intern Med 164:1275–1284PubMedCrossRef Kassan SS, Moutsopoulos HM (2004) Clinical manifestations and early diagnosis of Sjögren syndrome. Arch Intern Med 164:1275–1284PubMedCrossRef
2.
Zurück zum Zitat Vitali C, Bombardieri S, Jonsson R et al (2002) European Study Group on Classification Criteria for Sjögren’s Syndrome. Classification criteria for Sjögren’s syndrome: a revised version of the European criteria proposed by the American European Consensus Group. Ann Rheum Dis 61:482–484CrossRef Vitali C, Bombardieri S, Jonsson R et al (2002) European Study Group on Classification Criteria for Sjögren’s Syndrome. Classification criteria for Sjögren’s syndrome: a revised version of the European criteria proposed by the American European Consensus Group. Ann Rheum Dis 61:482–484CrossRef
3.
Zurück zum Zitat Kassan SS, Thomas TL, Moutsopoulos HM et al (1978) Increased risk of lymphoma in sicca syndrome. Ann Intern Med 89:888–892PubMed Kassan SS, Thomas TL, Moutsopoulos HM et al (1978) Increased risk of lymphoma in sicca syndrome. Ann Intern Med 89:888–892PubMed
4.
Zurück zum Zitat Theander E, Henriksson G, Ljunberg O et al (2006) Lymphoma and other malignancies in primary Sjogren’s syndrome: a cohort study on cancer incidence and lymphoma predictors. Ann Rheum Dis 65:796–803PubMedCrossRef Theander E, Henriksson G, Ljunberg O et al (2006) Lymphoma and other malignancies in primary Sjogren’s syndrome: a cohort study on cancer incidence and lymphoma predictors. Ann Rheum Dis 65:796–803PubMedCrossRef
5.
Zurück zum Zitat Zintzaras E, Voulgarelis M, Moutsopoulos HM (2005) The risk of lymphoma development in autoimmune diseases: a meta-analysis. Arch Intern Med 165:2337–2344PubMedCrossRef Zintzaras E, Voulgarelis M, Moutsopoulos HM (2005) The risk of lymphoma development in autoimmune diseases: a meta-analysis. Arch Intern Med 165:2337–2344PubMedCrossRef
6.
Zurück zum Zitat Baimpa E, Dahabreh IJ, Voulgarelis M, Moutsopoulos HM (2009) Hematologic manifestations and predictors of lymphoma development in primary Sjögren syndrome: clinical and pathophysiologic aspects. Medicine (Baltimore) 88:284–293CrossRef Baimpa E, Dahabreh IJ, Voulgarelis M, Moutsopoulos HM (2009) Hematologic manifestations and predictors of lymphoma development in primary Sjögren syndrome: clinical and pathophysiologic aspects. Medicine (Baltimore) 88:284–293CrossRef
7.
Zurück zum Zitat Ramos-Casals M, Brito-Zeron P, Perez-de-Lis M et al (2010) Clinical and prognostic significance of parotid scintigraphy in 405 patients with primary Sjogren’s syndrome. J Rheumatol 37:585–590PubMedCrossRef Ramos-Casals M, Brito-Zeron P, Perez-de-Lis M et al (2010) Clinical and prognostic significance of parotid scintigraphy in 405 patients with primary Sjogren’s syndrome. J Rheumatol 37:585–590PubMedCrossRef
8.
Zurück zum Zitat Anderson LA, Gadalla S, Morton LM et al (2009) Population-based study of auto-immune conditions and the risk of specific lymphoid malignancies. Int J Cancer 125:398–405PubMedCrossRef Anderson LA, Gadalla S, Morton LM et al (2009) Population-based study of auto-immune conditions and the risk of specific lymphoid malignancies. Int J Cancer 125:398–405PubMedCrossRef
9.
Zurück zum Zitat Ekström Smedby K, Hjalgrim H, Askling J et al (2006) Autoimmune and chronic inflammatory disorders and risk of non-Hodgkin lymphoma by subtype. J Natl Cancer Inst 98:51–60CrossRef Ekström Smedby K, Hjalgrim H, Askling J et al (2006) Autoimmune and chronic inflammatory disorders and risk of non-Hodgkin lymphoma by subtype. J Natl Cancer Inst 98:51–60CrossRef
10.
Zurück zum Zitat Ekström-Smedby K, Vajdic CM, Falster M et al (2008) Autoimmune disorders and risk of non-Hodgkin lymphoma subtypes: a pooled analysis within the InterLymph Consortium. Blood 111:4029–4038PubMedCrossRef Ekström-Smedby K, Vajdic CM, Falster M et al (2008) Autoimmune disorders and risk of non-Hodgkin lymphoma subtypes: a pooled analysis within the InterLymph Consortium. Blood 111:4029–4038PubMedCrossRef
11.
Zurück zum Zitat Zhang W, Feng S, Yan S et al (2010) Incidence of malignancy in primary Sjögren’s syndrome in a Chinese cohort. Rheumatology (Oxford) 49:571–577CrossRef Zhang W, Feng S, Yan S et al (2010) Incidence of malignancy in primary Sjögren’s syndrome in a Chinese cohort. Rheumatology (Oxford) 49:571–577CrossRef
Metadaten
Titel
Parotid gland non-Hodgkin lymphoma in primary Sjögren syndrome
verfasst von
Thierry Zenone
Publikationsdatum
01.05.2012
Verlag
Springer-Verlag
Erschienen in
Rheumatology International / Ausgabe 5/2012
Print ISSN: 0172-8172
Elektronische ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-011-1851-9

Weitere Artikel der Ausgabe 5/2012

Rheumatology International 5/2012 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.